These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33401139)

  • 1. Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection.
    Khachatoorian Y; Khachadourian V; Chang E; Sernas ER; Reed EF; Deng M; Piening BD; Pereira AC; Keating B; Cadeiras M
    Transplant Rev (Orlando); 2021 Jan; 35(1):100590. PubMed ID: 33401139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).
    DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR
    J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant.
    Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ
    Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Allograft Longevity: Leveraging Omics Technologies to Improve Heart Transplant Outcomes.
    Truby LK; Maamari D; Saha A; Farr M; Abdulrahim J; Billia F; Peltz M; Khush KK; Wang TJ
    Curr Heart Fail Rep; 2023 Dec; 20(6):493-503. PubMed ID: 37966542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients.
    Moayedi Y; Foroutan F; Miller RJH; Fan CS; Posada JGD; Alhussein M; Tremblay-Gravel M; Oro G; Luikart HI; Yee J; Shullo MA; Khush KK; Ross HJ; Teuteberg JJ
    J Heart Lung Transplant; 2019 Jan; 38(1):51-58. PubMed ID: 30352779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining donor derived cell free DNA and gene expression profiling for non-invasive surveillance after heart transplantation.
    Henricksen EJ; Moayedi Y; Purewal S; Twiggs JV; Waddell K; Luikart H; Han J; Feng K; Wayda B; Lee R; Shudo Y; Jimenez S; Khush KK; Teuteberg JJ
    Clin Transplant; 2023 Mar; 37(3):e14699. PubMed ID: 35559582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation.
    Rodgers N; Gerding B; Cusi V; Vaida F; Tada Y; Morris GP; Adler ED; Stehlik J; Kim PJ
    Clin Transplant; 2023 Jun; 37(6):e14984. PubMed ID: 37036133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of Immune Function in Heart Transplantation: Implications for Immunosuppression and Screening for Rejection.
    Zhuo DX; Ginder K; Hardin EA
    Curr Heart Fail Rep; 2021 Apr; 18(2):33-40. PubMed ID: 33400150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients - A Proof-of-Concept Study.
    Kamath M; Shekhtman G; Grogan T; Hickey MJ; Silacheva I; Shah KS; Shah KS; Hairapetian A; Gonzalez D; Godoy G; Reed EF; Elashoff D; Bondar G; Deng MC
    Front Immunol; 2022; 13():825108. PubMed ID: 35251005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The End of Endomyocardial Biopsy?: A Practical Guide for Noninvasive Heart Transplant Rejection Surveillance.
    Holzhauser L; DeFilippis EM; Nikolova A; Byku M; Contreras JP; De Marco T; Hall S; Khush KK; Vest AR
    JACC Heart Fail; 2023 Mar; 11(3):263-276. PubMed ID: 36682960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive biomarkers in heart transplant: 2020-2021 year in review.
    Qian X; Shah P; Agbor-Enoh S
    Curr Opin Organ Transplant; 2022 Feb; 27(1):7-14. PubMed ID: 34939959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-derived cell-free DNA is associated with cardiac allograft vasculopathy.
    Holzhauser L; Clerkin KJ; Fujino T; Alenghat FJ; Raikhelkar J; Kim G; Sayer G; Uriel N
    Clin Transplant; 2021 Mar; 35(3):e14206. PubMed ID: 33368611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients.
    Gondi KT; Kao A; Linard J; Austin BA; Everley MP; Fendler TJ; Khumri T; Lawhorn SL; Magalski A; Nassif ME; Sperry BW; Vodnala D; Borkon AM
    Clin Transplant; 2021 May; 35(5):e14258. PubMed ID: 33606316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoring.
    Mehlman Y; Valledor AF; Moeller C; Rubinstein G; Lotan D; Rahman S; Oh KT; Bae D; DeFilippis EM; Lin EF; Lee SH; Raikhelkar JK; Fried J; Theodoropoulos K; Colombo PC; Yuzefpolskaya M; Latif F; Clerkin KJ; Sayer GT; Uriel N
    Clin Transplant; 2023 Dec; 37(12):e15131. PubMed ID: 37897211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Validation of an Immune Quiescence Gene Expression Signature in Kidney Transplantation.
    Akalin E; Weir MR; Bunnapradist S; Brennan DC; Delos Santos R; Langone A; Djamali A; Xu H; Jin X; Dholakia S; Woodward RN; Bromberg JS
    Kidney360; 2021 Dec; 2(12):1998-2009. PubMed ID: 35419538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection.
    Lim JH; Chung BH; Lee SH; Jung HY; Choi JY; Cho JH; Park SH; Kim YL; Kim CD
    Korean J Intern Med; 2022 May; 37(3):520-533. PubMed ID: 35417937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
    Kataria A; Kumar D; Gupta G
    Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free DNA in lung transplantation: research tool or clinical workhorse?
    Keller M; Agbor-Enoh S
    Curr Opin Organ Transplant; 2022 Jun; 27(3):177-183. PubMed ID: 35649108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.